Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	2406.79	812.30	32.40
Graham Fair Price	-52.63	4.01	8.46
PEG	823.06	0.67	0.07
Price/Book	14.93	2.05	1.78
Price/Cash Flow	-95.81	-22.82	544.79
Prices/Earnings	-277.84	-49.19	-13.02
Price/Sales	35.91	3.25	2.39
Price/FCF	-95.81	-22.82	544.79
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-77.92	0.04	0.16
Operating Margin	-47.11	-0.05	0.09
ROA	71.72	< 0.005	< 0.005
ROE	-0.03	-0.01	69.58
ROIC	0.02	-0.01	-44.16
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	0.58	-93.29
Dividends QOQ	1.77	-1.00	-43.53
EBIT QOQ	3.24	-1.40	-56.82
EPS QOQ	-1.80	0.74	-59.07
FCF QOQ	-0.99	-25.54	-2475.11
Revenue QOQ	-0.01	-0.24	-2177.49
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	38.00	43.33	14.04
Days Sales Outstanding (DSO)	147.91	191.74	29.63
Inventory Turnover	2.37	2.08	-12.31
Debt/Capitalization	0.73	0.74	1.89
Quick Ratio	2.35	2.09	-11.08
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	9.63	8.28	-14.10
Cash	14.43	11.73	-18.71
Capex	-0.25	-0.16	35.98
Free Cash Flow	0.03	-0.74	2256.61
Revenue	7.18	5.22	-27.36
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.58	2.31	-10.34
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.30	384.06	2410.66
Naive Interpretation	Member

06 - Financial Health · Bad

Rating